Amedisys logo

Amedisys IPO

Amedisys is a leading provider of home health, hospice, and personal care services across the United States. The company serves patients in their homes through a network of care centers and healthcare professionals. Investors previously valued the company for its position in the growing home healthcare market driven by an aging population.

AcquiredUpdated April 2, 2026

Key Facts

IndustryHome Healthcare
Founded1982
HeadquartersBaton Rouge, LA
Employees~40,000
Websiteamedisys.com
FundingAcquired by UnitedHealth Group for $3.3B in 2023

About Amedisys

Amedisys operates as one of the largest providers of home health, hospice, and personal care services in the United States, serving patients across 38 states through a network of approximately 500 care centers. The company provides skilled nursing, physical therapy, occupational therapy, speech therapy, and social work services in patients' homes, focusing on post-acute care and chronic disease management. Amedisys has built its reputation on clinical excellence and patient satisfaction while maintaining strong relationships with hospital systems and physician groups for patient referrals.

The company's growth strategy has centered on both organic expansion and strategic acquisitions, allowing it to scale operations while maintaining local market expertise and relationships. Amedisys has invested heavily in technology platforms to improve care coordination, clinical outcomes measurement, and operational efficiency. Their integrated approach to home-based care has become increasingly valuable as healthcare systems seek to reduce costs while improving patient outcomes, particularly for elderly populations and those with chronic conditions who benefit from receiving care in familiar home environments.

IPO Status

Amedisys was a publicly traded company on NASDAQ under the ticker 'AMED' until it was acquired by UnitedHealth Group's Optum division in 2024. The acquisition was valued at approximately $3.3 billion, representing a significant premium to the company's trading price. The acquisition was part of UnitedHealth's strategy to expand its home-based care capabilities and integrate healthcare services. Amedisys shareholders received cash for their shares when the deal closed, and the company is no longer publicly traded as it operates as part of Optum's healthcare services division.

Competitors

Frequently Asked Questions

Does Amedisys have a stock?

Amedisys was previously a public company but completed its IPO many years ago. The company was acquired by UnitedHealth Group's Optum division in 2024 and is no longer publicly traded.

When is the Amedisys IPO date?

Amedisys is not planning an IPO as it was acquired by UnitedHealth Group in 2024. The company was previously public but is now part of Optum's healthcare services operations.

How can I buy Amedisys stock?

You cannot buy Amedisys stock as the company was acquired by UnitedHealth Group in 2024 and is no longer publicly traded. Investors interested in similar exposure might consider UnitedHealth Group (UNH) or other home healthcare companies.

Don't Miss the Next Big IPO

Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.

Get IPO Alerts

Related IPOs